COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval.

Sullivan DJ, Reik R, Prichard A, Pagan M, Tobian AAR, Caturegli P, Pekosz A, Klein SL, Bloch EM, Shoham S, Gebo KA, Joyner MJ, Senefeld JW, Franchini M, Focosi D, Pandey S, Lane K, McBee NA, Pirofski LA, Casadevall A, Hanley DF

Open source

DOI: 10.1080/14787210.2026.2623136
Published: 2026 Jan
Container: Expert review of anti-infective therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14787210.2026.2623136,
  title = {COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval.},
  author = {Sullivan DJ and Reik R and Prichard A and Pagan M and Tobian AAR and Caturegli P and Pekosz A and Klein SL and Bloch EM and Shoham S and Gebo KA and Joyner MJ and Senefeld JW and Franchini M and Focosi D and Pandey S and Lane K and McBee NA and Pirofski LA and Casadevall A and Hanley DF},
  year = {2026},
  journal = {Expert review of anti-infective therapy},
  doi = {10.1080/14787210.2026.2623136},
  url = {https://doi.org/10.1080/14787210.2026.2623136}
}

RIS

TY  - JOUR
TI  - COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval.
AU  - Sullivan DJ
AU  - Reik R
AU  - Prichard A
AU  - Pagan M
AU  - Tobian AAR
AU  - Caturegli P
AU  - Pekosz A
AU  - Klein SL
AU  - Bloch EM
AU  - Shoham S
AU  - Gebo KA
AU  - Joyner MJ
AU  - Senefeld JW
AU  - Franchini M
AU  - Focosi D
AU  - Pandey S
AU  - Lane K
AU  - McBee NA
AU  - Pirofski LA
AU  - Casadevall A
AU  - Hanley DF
PY  - 2026
JO  - Expert review of anti-infective therapy
DO  - 10.1080/14787210.2026.2623136
UR  - https://doi.org/10.1080/14787210.2026.2623136
ER  -

APA

DJ, S., R, R., A, P., M, P., AAR, T., P, C., A, P., SL, K., EM, B., S, S., KA, G., MJ, J., JW, S., M, F., D, F., S, P., K, L., NA, M., LA, P., A, C., & DF, H. (2026). COVID-19 convalescent plasma safety and efficacy analysis for biologics license application approval.. Expert review of anti-infective therapy. https://doi.org/10.1080/14787210.2026.2623136

Source records

pubmed · retrieved 2026-09-26T01:21:10.352Z